Part B — General Provisions Respecting National Research Institutes
- §284 Directors of national research institutes
- §284a Advisory councils
- §284b Repealed.
- §284c Certain uses of funds
- §284d Definitions
- §284e Research on osteoporosis, Paget’s disease, and related bone disorders
- §284f Parkinson’s disease
- §284g Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism spectrum disorder
- §284h Pediatric Research Initiative
- §284i Autoimmune diseases
- §284j Muscular dystrophy research
- §284k Clinical research
- §284l Enhancement awards
- §284m Program for pediatric studies of drugs
- §284m–1 Pediatric Advisory Committee
- §284n Certain demonstration projects
- §284o Activities of the National Institutes of Health with respect to research on paralysis
- §284p Activities of the National Institutes of Health with respect to research with implications for enhancing daily function for persons with paralysis
- §284q Pain research
- §284q–1 NIH opioid research
- §284r Basic research
- §284s Tick-borne diseases